insulin (Biobras)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinsulin (Biobras)
Drug Alias Nameinsulin (Sidus)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk Farmaceutica do Brasil Ltda
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk Farmaceutica do Brasil Ltda
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A